Prediction of Risk Level and Survivability of Breast Cancer Patients Using Machine Learning Techniques

Abstract

Breast cancer is the preeminent cancer among women and the second main cause of mortality of cancer. Early detection of breast cancer and prediction of survivability after the cancer is the most consequential medicine area. In the present, for predicting and anticipating future survivability of breast cancer, several researches had been conducted and developed algorithms for breast cancer prediction and there are many treatment methods for breast cancer patients to determine the patient's ability to live and inability to survive. In this context, a proper risk prediction system was developed in Sri Lanka context for the general community who with or without a diagnosis of breast cancer could not be identified. Furthermore, for the patients who are diagnosed, there is no and no hierarchical system to predict the relationship between the survivals of patients. The aim of this study is to utilize risk variables to create a prediction model that is an adequate method for predicting the present risk level of a person and for the diagnosis of patients for the prediction of survivability of patients using the treatment of breast cancer. The proposed machine learning models are expected for integrating computer-aided diagnosis systems for detecting breast cancer disease and predicting survivability.

Country : Sri Lanka

1 Malindu Jethaka2 Manoja Methmini Abeysekara3 Malith Menaka4 Sajana Ransika Abeyrathne

  1. Faculty of Computing, Sri Lanka Institute of Information Technology, New Kandy RD, Malabe, Sri Lanka
  2. Faculty of Computing, Sri Lanka Institute of Information Technology, New Kandy RD, Malabe, Sri Lanka
  3. Faculty of Computing, Sri Lanka Institute of Information Technology, New Kandy RD, Malabe, Sri Lanka
  4. Faculty of Computing, Sri Lanka Institute of Information Technology, New Kandy RD, Malabe, Sri Lanka

IRJIET, Volume 7, Issue 6, June 2023 pp. 159-164

doi.org/10.47001/IRJIET/2023.706025

References

  1. W. IOL, K. KM, C. BJ, L. CLK and L. GM, "Cost effectiveness of mammography screening for Chinese women," PubMed.gov, 2007.
  2. X. Wang, Y. Huang, L. Li, H. Dai, F. Song and K. Chen, "Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis," in IEEE Access, vol. 6, pp. 37450-37460, 2018, doi: 10.1109/ACCESS.2018.2855629.
  3. A.C. Antoniou, A. P. Cunningham and J. Peto, "The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions," in British Journal of Cancer, vol. 98, no. 8, pp. 1457-1466, 2008, doi: 10.1038/sj.bjc.6604308.
  4. Z. Obermeyer and E. Emanuel, "Predicting the Future - Big Data, Machine Learning, and Clinical Medicine," in New England Journal of Medicine, vol. 375, no. 13, pp. 1216-1219, 2016, doi: 10.1056/NEJMp1606181.
  5. R. L. Siegel, K. D. Miller, and A. Jemal, "Cancer statistics, 2018," CA Cancer J Clin, vol. 68, pp. 7-30, 2018.
  6. S. Chiaretti, X. Li, R. Gentleman, et al., "Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival," Blood, vol. 103, pp. 2771-2778, 2004.
  7. M. J. van de Vijver, Y. D. He, L. J. Van't Veer, et al., "A gene-expression signature as a predictor of survival in breast cancer," N Engl J Med, vol. 347, pp. 1999-2009, 2002.
  8. H. Y. Chang, D. S. Nuyten, J. B. Sneddon, et al., "Robustness, scalability, and integration of a wound response gene expression signature in predicting breast cancer survival," Proc Natl Acad Sci U S A, vol. 102, pp. 3738-3743, 2005.
  9. S. Z. Akhtar, "Spectroscopic Techniques for the Detection and Analysis of Urinary Tract Infection: A Review," J. Spectrosc., vol. 2021, article ID 8853251, 2021.
  10. Pereira B, Chin SF, Rueda OM, et al. The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes. Nat Commun. 2016; 7:11479.
  11. Li Y, Liu X, Tang H, Yang H, Meng X. RNA sequencing uncovers molecular mechanisms underlying pathological           complete response to chemotherapy in patients with operable breast cancer. Med Sci Monit. 2017; 23:4321–4327.
  12. Abou Tabl A, Alkhateeb A, ElMaraghy W, Ngom A. Machine learning model for identifying gene biomarkers for breast cancer treatment survival. Paper presented at: 8th ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics; August 20-23, 2017; Boston, MA: 607– 607. New York, NY: ACM.
  13. Pizzini A, Aichner M, Sahanic S, Böhm A, Egger A, Hoermann G, et al. "The Role of Nutrition in COVID-19 Susceptibility and Severity: A Systematic Review of Observational Studies." Nutrients. vol. 14, no. 8, article 1586, Apr. 2022.
  14. A.Fernando, U. Jayarajah, S. Prabashani, E. Fernando and S. Seneviratne, "Incidence trends and patterns of breast cancer in Sri Lanka: An analysis of the national cancer database," BMC Cancer, vol. 18, 2018.